These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

283 related articles for article (PubMed ID: 11405868)

  • 1. High tumor grade in salivary gland mucoepidermoid carcinomas and loss of expression of transforming growth factor beta receptor type II.
    Dillard DG; Muller S; Cohen C; Bloch D; Del Gaudio JM; Gal AA
    Arch Otolaryngol Head Neck Surg; 2001 Jun; 127(6):683-6. PubMed ID: 11405868
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Enhanced tumorigenesis and reduced transforming growth factor-beta type II receptor in lung tumors from mice with reduced gene dosage of transforming growth factor-beta1.
    Kang Y; Mariano JM; Angdisen J; Moody TW; Diwan BA; Wakefield LM; Jakowlew SB
    Mol Carcinog; 2000 Oct; 29(2):112-26. PubMed ID: 11074608
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Transforming growth factor-beta 1 and its receptors in human lung cancer and mouse lung carcinogenesis.
    Kang Y; Prentice MA; Mariano JM; Davarya S; Linnoila RI; Moody TW; Wakefield LM; Jakowlew SB
    Exp Lung Res; 2000 Dec; 26(8):685-707. PubMed ID: 11195465
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Alterations of transforming growth factor beta1 (TGF-beta1) and TGFbeta receptor expressions with progression in Dunning rat prostatic adenocarcinoma sublines.
    Wikström P; Lindh G; Bergh A; Damber JE
    Urol Res; 1999 Jun; 27(3):185-93. PubMed ID: 10422820
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Parenchymal transforming growth factor beta-1: its type II receptor and Smad signaling pathway correlate with inflammation and fibrosis in chronic liver disease of viral etiology.
    Calabrese F; Valente M; Giacometti C; Pettenazzo E; Benvegnu L; Alberti A; Gatta A; Pontisso P
    J Gastroenterol Hepatol; 2003 Nov; 18(11):1302-8. PubMed ID: 14535988
    [TBL] [Abstract][Full Text] [Related]  

  • 6. [Expression and significance of basic fibroblast growth factor and transforming growth factor-beta 1 in mucoepidermoid carcinoma with different malignant degree].
    Cao YT; Zhao D; Yang S; Wang XY; Gao QH; Xuan M; Cao JF
    Sichuan Da Xue Xue Bao Yi Xue Ban; 2009 Sep; 40(5):881-4. PubMed ID: 19950605
    [TBL] [Abstract][Full Text] [Related]  

  • 7. TGF-beta receptor 2 downregulation in tumour-associated stroma worsens prognosis and high-grade tumours show more tumour-associated macrophages and lower TGF-beta1 expression in colon carcinoma: a retrospective study.
    Bacman D; Merkel S; Croner R; Papadopoulos T; Brueckl W; Dimmler A
    BMC Cancer; 2007 Aug; 7():156. PubMed ID: 17692120
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Increased expression of MUC-1 has close relation with patient survivor in high-grade salivary gland mucoepidermoid carcinoma.
    Siyi L; Shengwen L; Min R; Wenjun Y; Lizheng W; Chenping Z
    J Oral Pathol Med; 2014 Sep; 43(8):579-84. PubMed ID: 24725122
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Relation of type II transforming growth factor-beta receptor to hepatic fibrosis and hepatocellular carcinoma.
    Ueno T; Hashimoto O; Kimura R; Torimura T; Kawaguchi T; Nakamura T; Sakata R; Koga H; Sata M
    Int J Oncol; 2001 Jan; 18(1):49-55. PubMed ID: 11115538
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Transforming growth factor-beta isoform and receptor expression in chondrosarcoma of bone.
    Masi L; Malentacchi C; Campanacci D; Franchi A
    Virchows Arch; 2002 May; 440(5):491-7. PubMed ID: 12021923
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Abnormal expression of Endoglin and its receptor complex (TGF-β1 and TGF-β receptor II) as early angiogenic switch indicator in premalignant lesions of the colon mucosa.
    Bellone G; Gramigni C; Vizio B; Mauri FA; Prati A; Solerio D; Dughera L; Ruffini E; Gasparri G; Camandona M
    Int J Oncol; 2010 Nov; 37(5):1153-65. PubMed ID: 20878063
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Downregulation of transforming growth factor beta type II receptor in laryngeal carcinogenesis.
    Franchi A; Gallo O; Sardi I; Santucci M
    J Clin Pathol; 2001 Mar; 54(3):201-4. PubMed ID: 11253131
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Reduction in transforming growth factor-beta type II receptor in mouse lung carcinogenesis.
    Jakowlew SB; Moody TW; You L; Mariano JM
    Mol Carcinog; 1998 May; 22(1):46-56. PubMed ID: 9609100
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Expression of transforming growth factor-beta1 and transforming growth factor-beta receptors in hepatocellular carcinoma and dysplastic nodules.
    Paik SY; Park YN; Kim H; Park C
    Mod Pathol; 2003 Jan; 16(1):86-96. PubMed ID: 12527718
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Distinct mechanisms of TGF-beta1-mediated epithelial-to-mesenchymal transition and metastasis during skin carcinogenesis.
    Han G; Lu SL; Li AG; He W; Corless CL; Kulesz-Martin M; Wang XJ
    J Clin Invest; 2005 Jul; 115(7):1714-23. PubMed ID: 15937546
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Structural changes and alteration in expression of TGF-beta1 and its receptors in prostatic intraepithelial neoplasia (PIN) in the ventral prostate of noble rats.
    Wong YC; Xie W; Tsao SW
    Prostate; 2000 Dec; 45(4):289-98. PubMed ID: 11102953
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Relationship between major and minor salivary gland mucoepidermoid carcinoma malignancy grading and presence of stromal myofibroblasts: immunohistochemical study.
    Sobral AP; Loducca SV; Nunes FD; de Araújo NS; Kowalski LP; de Araújo VC
    J Oral Pathol Med; 2004 Jul; 33(6):335-9. PubMed ID: 15200481
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Acetaldehyde stimulates the activation of latent transforming growth factor-beta1 and induces expression of the type II receptor of the cytokine in rat cultured hepatic stellate cells.
    Chen A
    Biochem J; 2002 Dec; 368(Pt 3):683-93. PubMed ID: 12223100
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Loss of expression of transforming growth factor beta type II receptor correlates with high tumour grade in human breast in-situ and invasive carcinomas.
    Gobbi H; Arteaga CL; Jensen RA; Simpson JF; Dupont WD; Olson SJ; Schuyler PA; Plummer WD; Page DL
    Histopathology; 2000 Feb; 36(2):168-77. PubMed ID: 10672063
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Transforming growth factor-beta expression in human testicular neoplasms.
    Cardillo MR; Petrangeli E; Ravenna L; Salvatori L; Di Silverio F
    Anal Quant Cytol Histol; 1998 Dec; 20(6):461-9. PubMed ID: 9870097
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 15.